Rockefeller Capital Management
FOLD

Rockefeller Capital Management’s Amicus Therapeutics FOLD Stock Holding History

Rockefeller Capital Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,786
Closed -$25.8K – 4782
2026
Q1 		$25.8K Buy
1,786
+324
+22% +$4.64K ﹤0.01% 3592
2025
Q4 		$20.8K Buy
1,462
+102
+8% +$1K ﹤0.01% 3501
2025
Q3 		$10.7K Buy
+1,360
New +$9.68K ﹤0.01% 3620
2023
Q1 		– Sell
-300
Closed -$3K – 2663
2022
Q4 		$3K Sell
300
-680
-69% -$7.66K ﹤0.01% 3460
2022
Q3 		$10K Sell
980
-146
-13% -$1.63K ﹤0.01% 3082
2022
Q2 		$12K Sell
1,126
-268
-19% -$2.21K ﹤0.01% 3009
2022
Q1 		$13K Sell
1,394
-755
-35% -$7.08K ﹤0.01% 2913
2021
Q4 		$24K Buy
2,149
+1,004
+88% +$11.2K ﹤0.01% 2558
2021
Q3 		$10K Sell
1,145
-69
-6% -$706 ﹤0.01% 2887
2021
Q2 		$11K Buy
1,214
+1,049
+636% +$10.2K ﹤0.01% 2738
2021
Q1 		$1K Sell
165
-883
-84% -$13.7K ﹤0.01% 3172
2020
Q4 		$24K Sell
1,048
-9,191
-90% -$188K ﹤0.01% 1931
2020
Q3 		$143K Buy
10,239
+858
+9% +$12.5K ﹤0.01% 1151
2020
Q2 		$142K Sell
9,381
-33
-0.4% -$402 ﹤0.01% 1050
2020
Q1 		$87K Sell
9,414
-3,086
-25% -$29.3K ﹤0.01% 1057
2019
Q4 		$122K Sell
12,500
-2,050
-14% -$18.8K ﹤0.01% 910
2019
Q3 		$117K Buy
14,550
+2,992
+26% +$32.5K ﹤0.01% 747
2019
Q2 		$144K Buy
11,558
+11,495
+18,246% +$146K ﹤0.01% 632
2019
Q1 		$1K Buy
+63
New +$770 ﹤0.01% 1852
2018
Q3 		– Sell
-19,169
Closed -$299K – 767
2018
Q2 		$299K Hold
19,169
– – ﹤0.01% 304
2018
Q1 		$288K Buy
+19,169
New +$292K ﹤0.01% 305

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Rockefeller Capital Management's FOLD Position: Q2 2026 in Review

Rockefeller Capital Management sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 1,786 shares — an estimated $25.8K sold.

Rockefeller Capital Management first reported a position in FOLD in Q1 2018 and held it in 21 quarters. The position peaked at $299K in Q2 2018. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • Rockefeller Capital Management reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Rockefeller Capital Management sold 1,786 Amicus Therapeutics shares in Q2 2026, an estimated $25.8K.
  • Rockefeller Capital Management first reported a position in Amicus Therapeutics in Q1 2018 and held it in 21 quarters.
  • Rockefeller Capital Management's Amicus Therapeutics position peaked at $299K in Q2 2018.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.